CVR: 21682977
Previous names: BIOGEN IDEC (DENMARK) A/S
DKK 178,728,185
Revenue
Net result: DKK 5,563,672
Biogen Netherlands B.V.
CVR · view ownership and management
Director role ended: Morten Lofthus Tangnes
CVR · 31/03/2026
View the full event history
BIOGEN (DENMARK) A/S is a Danish company of the type Aktieselskab based in Hellerup, founded in 1999. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named BIOGEN IDEC (DENMARK) A/S. The management consists of Erik Magnus Bodin. The company is owned by Biogen Netherlands B.V.. The company has 20 employees (2018). In 2025, the company reported revenue of DKK 178,728,185 and a net result of DKK 5,563,672 compared with DKK 7,526,703 the year before. Equity in the 2025 report amounted to DKK 151,886,117.
Source: annual report 2025, Danish Business Authority
The financial health of BIOGEN (DENMARK) A/S shows a concerning downward trend in revenue and profitability over the past few years. Revenue decreased from 307.5 million DKK in 2022 to 178.7 million DKK in 2025, while profit also declined from 8.4 million DKK to 5.6 million DKK in the same period. Despite this decline, the company's equity has increased to 151.9 million DKK, indicating a strong equity position. However, the declining revenue and profit margins raise concerns about its competitive position within the medical supplies industry.
AI-generated summary · Generated 30/06/2026
Selskabets formål er at markedsføre og distribuere lægemidler samt, direkte eller indirekte, at drive anden virksomhed, der efter bestyrelsens skøn er forbunden dermed
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 178.7 mio. | 5.6 mio. | 187.2 mio. | 151.9 mio. | 20 | |
| 202401/01/2024 – 31/12/2024 | 234 mio. | 7.5 mio. | 191.1 mio. | 146.3 mio. | 22 | |
| 202301/01/2023 – 31/12/2023 | 259.6 mio. | 8.3 mio. | 198.6 mio. | 138.8 mio. | 24 | |
| 202201/01/2022 – 31/12/2022 | 307.5 mio. | 8.4 mio. | 160.3 mio. | 130.5 mio. | 24 | |
| 202101/01/2021 – 31/12/2021 | 259.7 mio. | 7.6 mio. | 243.2 mio. | 122 mio. | 22 | |
| 202001/01/2020 – 31/12/2020 | 303.4 mio. | 10.1 mio. | 177.2 mio. | 114.5 mio. | 25 | |
| 201901/01/2019 – 31/12/2019 | 324.9 mio. | 12.3 mio. | 210.6 mio. | 104.3 mio. | 27 | |
| 201801/01/2018 – 31/12/2018 | 355 mio. | 12.5 mio. | 198.6 mio. | 92.1 mio. | 24 | |
| 201701/01/2017 – 31/12/2017 | 349.5 mio. | 9.1 mio. | 154.5 mio. | 79.5 mio. | 29 | |
| 201601/01/2016 – 31/12/2016 | 392.1 mio. | 13 mio. | 174.7 mio. | 70.4 mio. | 26 | |
| 201501/01/2015 – 31/12/2015 | 298.4 mio. | 9.1 mio. | 112.2 mio. | 57.5 mio. | 29 | |
| 201401/01/2014 – 31/12/2014 | 297.9 mio. | 8.1 mio. | 124.9 mio. | 48.4 mio. | 26 | |
| 201301/01/2013 – 31/12/2013 | 204.9 mio. | 5.6 mio. | 112.7 mio. | 40.3 mio. | 25 |
Compared to 293 companies in Engroshandel med læge- og hospitalsartikler
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
11 public tenders won
Showing 10 of 11 contracts
See all won contracts on UdbudsScannerSources: TED (the EU tender database) and udbud.dk
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreBIOGEN (DENMARK) A/S was founded on 19 April 1999.
BIOGEN (DENMARK) A/S is registered under the industry Engroshandel med læge- og hospitalsartikler (industry code 464620).
BIOGEN (DENMARK) A/S had 20 employees in 2018 according to the Danish CVR register.
BIOGEN (DENMARK) A/S is owned by Biogen Netherlands B.V..
In 2025, BIOGEN (DENMARK) A/S reported revenue of DKK 178,728,185.
The management of BIOGEN (DENMARK) A/S consists of Erik Magnus Bodin.
Claim this page to add your logo and social links. Free to get started.
BIOGEN (DENMARK) A/S has published its annual report for 2025. Revenue came to DKK 178,728,185, and the net result was DKK 5,563,672.
Contact info changed: new phone: 77415757 (April 14, 2026).
Contact info changed: new phone: 77415757 (April 1, 2026).
As of March 31, 2026, Erik Magnus Bodin has joined the board of directors of BIOGEN (DENMARK) A/S.
As of March 31, 2026, Morten Lofthus Tangnes has left the board of directors of BIOGEN (DENMARK) A/S.
As of March 31, 2026, Erik Magnus Bodin is registered as director of BIOGEN (DENMARK) A/S.
As of March 31, 2026, Morten Lofthus Tangnes has stepped down as director of BIOGEN (DENMARK) A/S.
BIOGEN (DENMARK) A/S has won the tender "Amgros 2026 1.353.b" issued by Amgros I/S worth 2,321,995,000 DKK.
BIOGEN (DENMARK) A/S has won the tender "Rammeaftale om køb af Spinraza® (nusinersen)" issued by Amgros I/S worth 80,000,000 DKK.
BIOGEN (DENMARK) A/S has published its annual report for 2024. Revenue came to DKK 234,002,651, and the net result was DKK 7,526,703.
BIOGEN (DENMARK) A/S has won the tender "Rammeaftale om køb af Qalsody (tofersen)" issued by Amgros I/S worth 39,050,000 DKK.
BIOGEN (DENMARK) A/S has won the tender "Rammeaftale om køb af Skyclarys (omaveloxolon)" issued by Amgros I/S worth 41,500,000 DKK.
BIOGEN (DENMARK) A/S has won the tender "Amgros 2025 1.160.a" issued by Amgros I/S worth 456,000,000 DKK.
BIOGEN (DENMARK) A/S has won the tender "Amgros 2025 1.161.b" issued by Amgros I/S worth 472,500,000 DKK.
BIOGEN (DENMARK) A/S has won the tender "Amgros 2025 1.142.b" issued by Amgros I/S worth 391,000,000 DKK.
BIOGEN (DENMARK) A/S has won the tender "Amgros 2025 1.351.b" issued by Amgros I/S worth 22,702,680,000 DKK.
BIOGEN (DENMARK) A/S has won the tender "Amgros 2025 1.130.b" issued by Amgros I/S worth 630,000,000 DKK.
BIOGEN (DENMARK) A/S has won the tender "Amgros 2025 1.132.b" issued by Amgros I/S worth 188,000,000 DKK.
BIOGEN (DENMARK) A/S has published its annual report for 2023. Revenue came to DKK 259,564,233, and the net result was DKK 8,338,739.
BIOGEN (DENMARK) A/S has won the tender "Amgros 2024 1.351.b" issued by Amgros I/S worth 19,644,800,000 DKK.
As of December 1, 2023, Morten Lofthus Tangnes has joined the board of directors of BIOGEN (DENMARK) A/S.
As of December 1, 2023, Louise Hammerich has left the board of directors of BIOGEN (DENMARK) A/S.
As of December 1, 2023, Morten Lofthus Tangnes is registered as director of BIOGEN (DENMARK) A/S.
As of December 1, 2023, Louise Hammerich has stepped down as adm. dir. of BIOGEN (DENMARK) A/S.
BIOGEN (DENMARK) A/S has published its annual report for 2022. Revenue came to DKK 307,509,784, and the net result was DKK 8,438,232.
As of December 1, 2022, Louise Hammerich has joined the board of directors of BIOGEN (DENMARK) A/S.
As of December 1, 2022, Tashia Susana Lentz has left the board of directors of BIOGEN (DENMARK) A/S.
As of December 1, 2022, Louise Hammerich is registered as adm. dir. of BIOGEN (DENMARK) A/S.
As of December 1, 2022, Tashia Susana Lentz has stepped down as adm. dir. of BIOGEN (DENMARK) A/S.
As of September 1, 2022, Sergio Ferreira da Silva Teixeira has joined the board of directors of BIOGEN (DENMARK) A/S.
As of August 31, 2022, Ulf Johan Ström has left the board of directors of BIOGEN (DENMARK) A/S.
BIOGEN (DENMARK) A/S has published its annual report for 2021. Revenue came to DKK 259,684,984, and the net result was DKK 7,551,843.
BIOGEN (DENMARK) A/S has published its annual report for 2020. Revenue came to DKK 303,396,452, and the net result was DKK 10,121,961.
As of June 1, 2021, Tashia Susana Lentz has joined the board of directors of BIOGEN (DENMARK) A/S.
As of June 1, 2021, Janne Harder Holmelund has left the board of directors of BIOGEN (DENMARK) A/S.
As of June 1, 2021, Tashia Susana Lentz is registered as adm. dir. of BIOGEN (DENMARK) A/S.
As of June 1, 2021, Janne Harder Holmelund has stepped down as adm. dir. of BIOGEN (DENMARK) A/S.
BIOGEN (DENMARK) A/S has published its annual report for 2019. Revenue came to DKK 324,931,439, and the net result was DKK 12,285,122.
BIOGEN (DENMARK) A/S has published its annual report for 2018. Revenue came to DKK 354,996,821, and the net result was DKK 12,526,911.
BIOGEN (DENMARK) A/S has published its annual report for 2017. Revenue came to DKK 349,466,112, and the net result was DKK 9,095,758.
As of July 10, 2017, Ulf Johan Ström has joined the board of directors of BIOGEN (DENMARK) A/S.
As of July 10, 2017, Vesna Leskovsek Cizej has left the board of directors of BIOGEN (DENMARK) A/S.
BIOGEN (DENMARK) A/S has published its annual report for 2016. Revenue came to DKK 392,113,116, and the net result was DKK 12,980,189.
BIOGEN (DENMARK) A/S has published its annual report for 2015. Revenue came to DKK 298,427,977, and the net result was DKK 9,088,920.
As of March 1, 2016, Neil Raymond Sisak has joined the board of directors of BIOGEN (DENMARK) A/S.
As of March 1, 2016, Steven John Green has left the board of directors of BIOGEN (DENMARK) A/S.
As of February 29, 2016, Neil Raymond Sisak has left the board of directors of BIOGEN (DENMARK) A/S.
As of January 31, 2016, Neil Raymond Sisak has joined the board of directors of BIOGEN (DENMARK) A/S.
As of July 1, 2015, Vesna Leskovsek Cizej has joined the board of directors of BIOGEN (DENMARK) A/S.
As of July 1, 2015, Thomas Lackner has left the board of directors of BIOGEN (DENMARK) A/S.
BIOGEN (DENMARK) A/S has published its annual report for 2014. Revenue came to DKK 297,858,497, and the net result was DKK 8,064,013.
As of April 1, 2015, Thomas Francois Etienne Biet has left the board of directors of BIOGEN (DENMARK) A/S.
As of March 31, 2015, Steven John Green has joined the board of directors of BIOGEN (DENMARK) A/S.
On March 23, 2015, the company changed its name from BIOGEN IDEC (DENMARK) A/S to BIOGEN (DENMARK) A/S.
BIOGEN (DENMARK) A/S has published its annual report for 2013. Revenue came to DKK 204,862,605, and the net result was DKK 5,592,430.
BIOGEN (DENMARK) A/S has published its annual report for 2012.
As of December 4, 2012, Neil Raymond Sisak has left the board of directors of BIOGEN (DENMARK) A/S.
As of October 4, 2012, Janne Harder Holmelund has joined the board of directors of BIOGEN (DENMARK) A/S.
As of October 4, 2012, Allan Frank Fischer Petersen has joined the board of directors of BIOGEN (DENMARK) A/S.
As of October 4, 2012, Charlotte Leife has left the board of directors of BIOGEN (DENMARK) A/S.
As of September 25, 2012, Janne Harder Holmelund is registered as adm. dir. of BIOGEN (DENMARK) A/S.
As of September 25, 2012, Charlotte Leife has stepped down as adm. dir. of BIOGEN (DENMARK) A/S.
As of May 14, 2012, Thomas Francois Etienne Biet has joined the board of directors of BIOGEN (DENMARK) A/S.
As of May 14, 2012, Peter Rützou-Hjelmkrone has left the board of directors of BIOGEN (DENMARK) A/S.
As of July 1, 2011, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of BIOGEN (DENMARK) A/S.
As of July 1, 2011, A/S PSE NR. 4820 has stepped down as auditor of BIOGEN (DENMARK) A/S.
As of March 4, 2011, Thomas Lackner has joined the board of directors of BIOGEN (DENMARK) A/S.
As of March 4, 2011, Neil Raymond Sisak has joined the board of directors of BIOGEN (DENMARK) A/S.
As of March 4, 2011, David Gregory Davis has left the board of directors of BIOGEN (DENMARK) A/S.
As of April 30, 2010, Peter Rützou-Hjelmkrone has joined the board of directors of BIOGEN (DENMARK) A/S.
As of April 30, 2010, Peter Lindborg has left the board of directors of BIOGEN (DENMARK) A/S.
As of March 30, 2009, David Gregory Davis has joined the board of directors of BIOGEN (DENMARK) A/S.
As of December 29, 2008, is registered as an owner of BIOGEN (DENMARK) A/S with an ownership share of 100%.
As of September 30, 2008, Johny Humaloja has left the board of directors of BIOGEN (DENMARK) A/S.
As of August 2, 2005, Peter Rützou-Hjelmkrone has stepped down as director of BIOGEN (DENMARK) A/S.
As of August 2, 2005, Randolph Spicochi has stepped down as director of BIOGEN (DENMARK) A/S.
As of August 2, 2005, Francis Marsland has stepped down as director of BIOGEN (DENMARK) A/S.
As of June 30, 2005, A/S PSE NR. 4820 has been appointed auditor of BIOGEN (DENMARK) A/S.
As of June 30, 2005, Pricewaterhouse Coopers has stepped down as auditor of BIOGEN (DENMARK) A/S.
As of November 30, 2004, Peter Lindborg has joined the board of directors of BIOGEN (DENMARK) A/S.
As of November 30, 2004, Charlotte Leife has joined the board of directors of BIOGEN (DENMARK) A/S.
As of November 30, 2004, Johny Humaloja has joined the board of directors of BIOGEN (DENMARK) A/S.
As of November 30, 2004, Karl Anders Lundström has left the board of directors of BIOGEN (DENMARK) A/S.
As of November 30, 2004, Jean-Yves Boursier has left the board of directors of BIOGEN (DENMARK) A/S.
As of November 30, 2004, David Stephen Allsop has left the board of directors of BIOGEN (DENMARK) A/S.
As of November 30, 2004, Peter Rützou-Hjelmkrone is registered as director of BIOGEN (DENMARK) A/S.
As of November 30, 2004, Charlotte Leife is registered as adm. dir. of BIOGEN (DENMARK) A/S.
As of November 30, 2004, Randolph Spicochi is registered as director of BIOGEN (DENMARK) A/S.
As of November 30, 2004, Francis Marsland is registered as director of BIOGEN (DENMARK) A/S.
As of November 30, 2004, Karl Anders Lundström has stepped down as director of BIOGEN (DENMARK) A/S.
As of November 13, 2003, David Stephen Allsop has joined the board of directors of BIOGEN (DENMARK) A/S.
As of November 13, 2003, Francis Paul Edward Marsland has left the board of directors of BIOGEN (DENMARK) A/S.
On November 13, 2003, the company changed its name from BIOGEN (DENMARK) A/S to BIOGEN IDEC (DENMARK) A/S.
As of January 20, 2003, Jean-Yves Boursier has joined the board of directors of BIOGEN (DENMARK) A/S.
As of January 20, 2003, Francis Paul Edward Marsland has joined the board of directors of BIOGEN (DENMARK) A/S.
As of January 20, 2003, Patrick Volkert Jozef Johannes Vink has left the board of directors of BIOGEN (DENMARK) A/S.
As of January 16, 2002, Patrick Volkert Jozef Johannes Vink has joined the board of directors of BIOGEN (DENMARK) A/S.
As of January 16, 2002, James Henry Magnusen Kirkness has left the board of directors of BIOGEN (DENMARK) A/S.
As of January 16, 2001, Karl Anders Lundström has joined the board of directors of BIOGEN (DENMARK) A/S.
As of January 16, 2001, Karen Lykke Sørensen has left the board of directors of BIOGEN (DENMARK) A/S.
As of January 16, 2001, Peter Johan Lindborg has left the board of directors of BIOGEN (DENMARK) A/S.
As of January 16, 2001, Karl Anders Lundström is registered as director of BIOGEN (DENMARK) A/S.
As of January 16, 2001, Karen Lykke Sørensen has stepped down as director of BIOGEN (DENMARK) A/S.
As of March 3, 2000, Karen Lykke Sørensen has joined the board of directors of BIOGEN (DENMARK) A/S.
As of March 3, 2000, Tom Bork Petersen has left the board of directors of BIOGEN (DENMARK) A/S.
As of March 3, 2000, Karen Lykke Sørensen is registered as director of BIOGEN (DENMARK) A/S.
As of March 3, 2000, James Henry Magnusen Kirkness has stepped down as director of BIOGEN (DENMARK) A/S.
As of April 19, 1999, Pricewaterhouse Coopers has been appointed auditor of BIOGEN (DENMARK) A/S.
As of April 19, 1999, Tom Bork Petersen has joined the board of directors of BIOGEN (DENMARK) A/S.
As of April 19, 1999, Peter Johan Lindborg has joined the board of directors of BIOGEN (DENMARK) A/S.
As of April 19, 1999, James Henry Magnusen Kirkness has joined the board of directors of BIOGEN (DENMARK) A/S.
As of April 19, 1999, James Henry Magnusen Kirkness is registered as director of BIOGEN (DENMARK) A/S.
BIOGEN (DENMARK) A/S was founded on April 19, 1999.
Companies in the same industry and area
CVR 41344806
CVR 39870665
CVR 41747978
CVR 37231304
CVR 46354729
